Magdalena Chmielińska

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Disease Activity

Anti Inflammatory Drugs

Dendritic Cells

Rheumatoid Arthritis Patients

Top Venues

Rheumatology international

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Magdalena Chmielińska, Anna Felis-Giemza, Marzena Olesińska, Agnieszka Paradowska-Gorycka, Dariusz Szukiewicz
The failure of biological treatment in axial spondyloarthritis is linked to the factors related to increased intestinal permeability and dysbiosis: prospective observational cohort study. Rheumatology international 44 (8) (2024)
Magdalena Chmielińska, Anna Felis-Giemza, Marzena Olesińska, Agnieszka Paradowska-Gorycka, Dariusz Szukiewicz
The failure of biological treatment in axial spondyloarthritis is linked to the factors related to increased intestinal permeability and dysbiosis: prospective observational cohort study. Rheumatology international 44 (8) (2024)
Magdalena Chmielińska, Anna Felis-Giemza, Marzena Olesińska, Agnieszka Paradowska-Gorycka, Dariusz Szukiewicz
The failure of biological treatment in axial spondyloarthritis is linked to the factors related to increased intestinal permeability and dysbiosis: prospective observational cohort study. Rheumatology international (2024)
Magdalena Chmielińska, Anna Felis-Giemza, Marzena Olesińska, Agnieszka Paradowska-Gorycka, Dariusz Szukiewicz
The failure of biological treatment in axial spondyloarthritis is linked to the factors related to increased intestinal permeability and dysbiosis: prospective observational cohort study. Rheumatology international 44 (8) (2024)
Magdalena Chmielińska, Anna Felis-Giemza, Marzena Olesińska, Agnieszka Paradowska-Gorycka, Dariusz Szukiewicz
The failure of biological treatment in axial spondyloarthritis is linked to the factors related to increased intestinal permeability and dysbiosis: prospective observational cohort study. Rheumatology international 44 (8) (2024)
Magdalena Chmielińska, Anna Felis-Giemza, Marzena Olesińska, Agnieszka Paradowska-Gorycka, Dariusz Szukiewicz
The failure of biological treatment in axial spondyloarthritis is linked to the factors related to increased intestinal permeability and dysbiosis: prospective observational cohort study. Rheumatology international 44 (8) (2024)
Magdalena Chmielińska, Marzena Olesińska, Anna Felis-Giemza, Agnieszka Paradowska-Gorycka, Karolina Palej, Julita Rejmer-Szcześniak, Dariusz Szukiewicz
Predictors of treatment failure of non-steroidal anti-inflammatory drugs in patients with axial spondyloarthritis with focus on haptoglobin, haptoglobin polymorphism and zonulin. Rheumatology international (2023)
Magdalena Chmielińska, Marzena Olesińska, Katarzyna Romanowska-Próchnicka, Dariusz Szukiewicz
Haptoglobin and Its Related Protein, Zonulin-What Is Their Role in Spondyloarthropathy? Journal of clinical medicine 10 (5) (2021)